{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:04:26Z","timestamp":1785528266578,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13953-9","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:06:07Z","timestamp":1785463567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, resistance profile of ESKAPEE pathogens, and molecular detection of PMQR-associated genes among Levofloxacin-resistant gram-negative ESKAPEE isolates from critically-ill patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Sylvana Nady","family":"Gaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha H.","family":"Bassyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ashraf","family":"Wegdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar Saad","family":"Abd-elrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Fathy","family":"Elkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Makram","family":"Botros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A. F.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa Mohamed Eid","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"13953_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"S Mulani","year":"2019","unstructured":"Mulani S, Kamble E, Kumkar N, Tawre S, Pardesi R. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Front Microbiol. 2019;10:539.","journal-title":"Front Microbiol"},{"issue":"1","key":"13953_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/antibiotics14010051","volume":"14","author":"TH Endo","year":"2025","unstructured":"Endo TH, Santos MHM, Scandorieiro S, Gon\u00e7alves BC, Vespero EC, Perugini MRE, Pavanelli WR, Nakazato G, Kobayashi RKT. Selective Serotonin Reuptake Inhibitors: Antimicrobial Activity Against ESKAPEE Bacteria and Mechanisms of Action. Antibiotics. 2025;14(1):51. https:\/\/doi.org\/10.3390\/antibiotics14010051.","journal-title":"Antibiotics"},{"key":"13953_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318\u201327.","journal-title":"Lancet Infect Dis"},{"key":"13953_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet. 2022;399:629\u201355. [Google Scholar] [CrossRef].","journal-title":"Lancet"},{"key":"13953_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00088-17","volume":"31","author":"SR Partridge","year":"2018","unstructured":"Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile Genetic Elements Associated with Antimicrobial Resistance. Clin Microbiol Rev. 2018;31:10\u20131128. [Google Scholar] [CrossRef].","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"13953_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/jac\/dkx488","volume":"73","author":"M Rozwandowicz","year":"2018","unstructured":"Rozwandowicz M, Brouwer M, Fischer J, Wagenaar A, Gonzalez-Zorn B, Guerra B, et al. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother. 2018;73(5):1121\u201337.","journal-title":"J Antimicrob Chemother"},{"key":"13953_CR7","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2147\/IDR.S306688","volume":"14","author":"R Pandey","year":"2021","unstructured":"Pandey R, Mishra S, Shrestha A. Characterization of ESKAPE pathogens with special reference to multidrug resistance and biofilm production in a Nepalese hospital. Infect Drug Resist. 2021;14:2201\u201312.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"13953_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"J Aldred","year":"2014","unstructured":"Aldred J, Kerns J, Osheroff N. Mechanism of Quinolone Action and Resistance. Biochemistry. 2014;53(10):1565\u201374.","journal-title":"Biochemistry"},{"issue":"10","key":"13953_CR9","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/C9MD00120D","volume":"10","author":"M Pham","year":"2019","unstructured":"Pham M, Ziora Z, Blaskovich M. Quinolone antibiotics. Medchemcomm. 2019;10(10):1719\u201339.","journal-title":"Medchemcomm"},{"issue":"1","key":"13953_CR10","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.4102\/ajlm.v11i1.1594","volume":"11","author":"B Tornimbene","year":"2022","unstructured":"Tornimbene B, Eremin S, Abednego R, Abualas E, Boutiba I, Egwuenu A, et al. Global Antimicrobial Resistance and Use Surveillance System on the African continent: Early implementation 2017\u20132019. Afr J Lab Med. 2022;11(1):1594.","journal-title":"Afr J Lab Med"},{"issue":"1","key":"13953_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","volume":"1354","author":"D Hooper","year":"2015","unstructured":"Hooper D, Jacoby G. Mechanisms of drug resistance: quinolone resistance Ann. N Y Acad Sci. 2015;1354(1):12\u201331.","journal-title":"N Y Acad Sci"},{"issue":"5","key":"13953_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4067\/S0716-10182015000600002","volume":"32","author":"D \u00c1lvarez-Hern\u00e1ndez","year":"2015","unstructured":"\u00c1lvarez-Hern\u00e1ndez D, Garza-May\u00e9n G, V\u00e1zquez-L\u00f3pez R. Quinolones. Nowadays perspectives and mechanisms of resistance. Revista Chil de infectol. 2015;32(5):499\u2013504.","journal-title":"Revista Chil de infectol"},{"issue":"1","key":"13953_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1179\/1120009X12Z.00000000078","volume":"25","author":"B Kocsis","year":"2013","unstructured":"Kocsis B, Mazzariol A, Kocsis E, Koncan R, Fontana R, Cornaglia G. Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae strains isolated in North-East Italy. J Chemother. 2013;25(1):36\u201340.","journal-title":"J Chemother"},{"issue":"8","key":"13953_CR14","doi-asserted-by":"publisher","first-page":"e00718","DOI":"10.1128\/AAC.00718-19","volume":"63","author":"L Vinu\u00e9","year":"2019","unstructured":"Vinu\u00e9 L, Sater M, Herriott I, Huntley M, Jacoby G, Hooper D. Multiple Copies of qnrA1 on an IncA\/C2 plasmid explain enhanced quinolone resistance in an Escherichia coli mutant. Antimicrob Agents Chemother. 2019;63(8):e00718\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"13953_CR15","doi-asserted-by":"publisher","first-page":"104020","DOI":"10.1016\/j.meegid.2019.104020","volume":"76","author":"I Yassine","year":"2019","unstructured":"Yassine I, Rafei R, Osman M, Mallat H, Dabbouss F, Hamze M. Plasmid-mediated quinolone resistance: Mechanisms, detection, and epidemiology in the Arab countries. Infect Genet Evol. 2019;76:104020.","journal-title":"Infect Genet Evol"},{"issue":"2","key":"13953_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/mdr.2016.0033","volume":"23","author":"E Albornoz","year":"2017","unstructured":"Albornoz E, Lucero C, Romero G, Quiroga M, Rapoport M, Guerriero L, et al. Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Clinical Enterobacteria from Argentina. Microb Drug Resist. 2017;23(2):177\u201387.","journal-title":"Microb Drug Resist"},{"key":"13953_CR17","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3389\/fmicb.2017.01899","volume":"8","author":"V Manageiro","year":"2017","unstructured":"Manageiro V, F\u00e9lix D, Jones-Dias D, Sampaio D, Vieira L, Sancho L, Ferreira E, Cani\u00e7a M. Genetic background and expression of the new qepa4 gene variant recovered in clinical TEM-1- and CMY-2-producing Escherichia coli. Front Microbiol. 2017;8:1899.","journal-title":"Front Microbiol"},{"issue":"6","key":"13953_CR18","doi-asserted-by":"publisher","first-page":"300060522110670","DOI":"10.1177\/03000605221106705","volume":"50","author":"L Sun","year":"2022","unstructured":"Sun L, Sun J, Ding S. In vitro research of combination therapy for multidrug-resistant Klebsiella pneumoniae bloodstream infections. J Int Med Res. 2022;50(6):3000605221106705.","journal-title":"J Int Med Res"},{"key":"13953_CR19","volume-title":"Textbook of Diagnostic Microbiology","author":"C Mahon","year":"2014","unstructured":"Mahon C, Lehman D, Manuselis G. Textbook of Diagnostic Microbiology. 5th ed. Philadelphia, PA: Saunders; 2014.","edition":"5"},{"key":"13953_CR20","volume-title":"2021: performance standards for antimicrobial susceptibility testing. 31st Edition. CLSI guideline M 100","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2021","unstructured":"Clinical and Laboratory Standards Institute (CLSI). 2021: performance standards for antimicrobial susceptibility testing. 31st Edition. CLSI guideline M 100. Wayne, PA: Clinical and Laboratory Standards Institute; 2021."},{"key":"13953_CR21","doi-asserted-by":"publisher","first-page":"4065603","DOI":"10.1155\/2016\/4065603","volume":"2016","author":"S Basak","year":"2016","unstructured":"Basak S, Singh P, Rajurkar M. Multidrug Resistant and Extensively Drug-Resistant Bacteria: A Study. J pathogens. 2016;2016:4065603.","journal-title":"J pathogens"},{"issue":"3","key":"13953_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ph14030184","volume":"14","author":"E Engeman","year":"2021","unstructured":"Engeman E, Freyberger H, Corey B, Ward A, He Y, Nikolich M, et al. Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment. Pharmaceuticals (Basel Switzerland). 2021;14(3):184.","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"issue":"1","key":"13953_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","volume":"48","author":"J Andrews","year":"2001","unstructured":"Andrews J. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48(1):5\u201316.","journal-title":"J Antimicrob Chemother"},{"key":"13953_CR24","unstructured":"Lonsway D. Preparation of routine media and reagents used in antimicrobial susceptibility testing. In: Clinical Microbiology Procedures Handbook. 5th ed. Washington (DC): ASM Press; 2021."},{"issue":"6","key":"13953_CR25","doi-asserted-by":"publisher","first-page":"e00074","DOI":"10.1128\/AAC.00074-21","volume":"65","author":"H Huang","year":"2021","unstructured":"Huang H, Wang C, Lu P, Tseng S, Wang Y, Chen T, Chang K, Tu H, Lin S. Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with Enterobacterales Bacteremia. Antimicrob Agents Chemother. 2021;65(6):e00074\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"13953_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s43141-021-00219-x","volume":"19","author":"R Prashanthi","year":"2021","unstructured":"Prashanthi R, Shreevatsa G, Krupalini S, Manoj L. Isolation, characterization, and molecular identification of soil bacteria showing antibacterial activity against human pathogenic bacteria. J Genet Eng Biotechnol. 2021;19:120.","journal-title":"J Genet Eng Biotechnol"},{"issue":"1","key":"13953_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bjm.2015.04.001","volume":"47","author":"B Pribul","year":"2016","unstructured":"Pribul B, Festivo M, de Souza M, Rodrigues D. Characterization of quinolone resistance in Salmonella spp. isolates from food products and human samples in Brazil. Brazilian J Microbiol. 2016;47(1):196\u2013201.","journal-title":"Brazilian J Microbiol"},{"issue":"2","key":"13953_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jac\/dkm204","volume":"60","author":"V Cattoir","year":"2007","unstructured":"Cattoir V, Poirel L, Rotimi V, Soussy J, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007;60(2):394\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"13953_CR29","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1128\/AAC.06191-11","volume":"56","author":"X Chen","year":"2012","unstructured":"Chen X, Zhang W, Pan W, Yin J, Pan Z, Gao S, Jiao X. Prevalence of qnr, aac (6\u2019)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment. Antimicrob Agents Chemother. 2012;56(6):3423\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"13953_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13756-019-0590-7","volume":"8","author":"X Zhen","year":"2019","unstructured":"Zhen X, Lundborg C, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8:137.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13953_CR31","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2147\/IDR.S312231","volume":"14","author":"M Arbune","year":"2021","unstructured":"Arbune M, Gurau G, Niculet E, Iancu V, Lupasteanu G, Fotea S, et al. Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania. Infect Drug Resist. 2021;14:2369\u201378.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"13953_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3947\/ic.2021.0015","volume":"53","author":"W Flores-Paredes","year":"2021","unstructured":"Flores-Paredes W, Luque N, Albornoz R, Rojas N, Espinoza M, Pons M, et al. Evolution of antimicrobial resistance levels of ESKAPE microorganisms in a Peruvian IV-level hospital. Infect Chemother. 2021;53(3):449\u201362.","journal-title":"Infect Chemother"},{"issue":"1","key":"13953_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13756-020-00871-x","volume":"10","author":"Y Saharman","year":"2021","unstructured":"Saharman Y, Karuniawati A, Severin J, Verbrugh H. Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control. 2021;10(1):22.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"13953_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4314\/ahs.v21i2.5","volume":"21","author":"M Gemechu","year":"2021","unstructured":"Gemechu M, Tadesse T, Takele G, Bisetegram F, Gesese Y, Zelelie T. Bacterial profile and their antimicrobial susceptibility patterns in patients admitted at Madda Walabu University Goba Referral Hospital, Ethiopia: a cross-sectional study. Afr Health Sci. 2021;21(2):513\u201322.","journal-title":"Afr Health Sci"},{"issue":"6","key":"13953_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000346352","volume":"58","author":"J Llaca-D\u00edaz","year":"2021","unstructured":"Llaca-D\u00edaz J, Mendoza-Olazar\u00e1n S, Camacho-Ortiz A, Flores S, Garza-Gonz\u00e1lez E. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey. Mexico Chemother. 2021;58(6):475\u201381.","journal-title":"Mexico Chemother"},{"issue":"1","key":"13953_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1186\/s12879-019-4721-9","volume":"19","author":"K Rothe","year":"2019","unstructured":"Rothe K, Wantia N, Spinner C, Schneider J, Lahmer T, Waschulzik B, et al. antimicrobial resistance of bacteremia in the emergency department of a German university hospital (2013\u20132018): Potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations. BMC Infect Dis. 2019;19(1):1091.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"13953_CR37","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3390\/ijms21061914","volume":"21","author":"E Palma","year":"2020","unstructured":"Palma E, Tilocca B, Roncada P. Antimicrobial resistance in veterinary medicine: An overview. Int J Mol Sci. 2020;21(6):1914.","journal-title":"Int J Mol Sci"},{"key":"13953_CR38","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1017\/S0950268822001492","volume":"150","author":"EI Kritsotakis","year":"2022","unstructured":"Kritsotakis EI, Lagoutari D, Michailellis E, Georgakakis I, Gikas A. Burden of multidrug and extensively drug-resistant ESKAPEE pathogens in a secondary hospital care setting in Greece. Epidemiol Infect. 2022;150:e170. https:\/\/doi.org\/10.1017\/S0950268822001492.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"13953_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/bacteria3020006","volume":"3","author":"K Ravi","year":"2024","unstructured":"Ravi K, Singh BESKAPE. Navigating the Global Battlefield for Antimicrobial Resistance and Defense in Hospitals. Bacteria. 2024;3(2):76\u201398.","journal-title":"Bacteria"},{"key":"13953_CR40","doi-asserted-by":"publisher","first-page":"109637","DOI":"10.1016\/j.celrep.2021.109637","volume":"36","author":"N Rhoades","year":"2021","unstructured":"Rhoades N, Pinski A, Monsibais A, Jankeel A, Doratt B, Cinco I, Ibraim I, Messaoudi I. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose. Cell Rep. 2021;36:109637.","journal-title":"Cell Rep"},{"issue":"1","key":"13953_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12866-023-02849-2","volume":"23","author":"K Kariuki","year":"2023","unstructured":"Kariuki K, Diakhate M, Musembi S, Tornberg-Belanger S, Rwigi D, Mutuma T, et al. Plasmid-mediated quinolone resistance genes detected in Ciprofloxacin non-susceptible Escherichia coli and Klebsiella isolated from children under five years at hospital discharge, Kenya. BMC Microbiol. 2023;23(1):129.","journal-title":"BMC Microbiol"},{"issue":"1","key":"13953_CR42","first-page":"1","volume":"8","author":"M Nejma","year":"2018","unstructured":"Nejma M, Sioud O, Mastouri M. Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia. Biotech. 2018;8(1):1.","journal-title":"Biotech"},{"key":"13953_CR43","doi-asserted-by":"publisher","first-page":"8050432","DOI":"10.1155\/2017\/8050432","volume":"2017","author":"M El-Badawy","year":"2017","unstructured":"El-Badawy M, Tawakol W, El-Far S, Maghrabi I, Al-Ghamdi S, Mansy M, et al. Molecular Identification of Aminoglycoside-Modifying Enzymes and Plasmid-Mediated Quinolone Resistance Genes among Klebsiella pneumoniae Clinical Isolates Recovered from Egyptian Patients. Int J Microbiol. 2017;2017:8050432.","journal-title":"Int J Microbiol"},{"issue":"2021","key":"13953_CR44","first-page":"6468942","volume":"4","author":"S Abdel-Rhman","year":"2021","unstructured":"Abdel-Rhman S, El-bargisy R, Rizk D. Characterization of Integrons and Quinolone Resistance in Clinical Escherichia coli Isolates in Mansoura City, Egypt. Int J Microbiol. 2021;4(2021):6468942.","journal-title":"Int J Microbiol"},{"issue":"7","key":"13953_CR45","doi-asserted-by":"publisher","first-page":"e24342","DOI":"10.1002\/jcla.24342","volume":"36","author":"N Jomehzadeh","year":"2022","unstructured":"Jomehzadeh N, Ahmadi K, Bahmanshiri M. Investigation of plasmid-mediated quinolone resistance genes among clinical isolates of Klebsiella pneumoniae in southwest Iran. Clin Lab Anal. 2022;36(7):e24342.","journal-title":"Clin Lab Anal"},{"issue":"12","key":"13953_CR46","doi-asserted-by":"publisher","first-page":"e0261970","DOI":"10.1371\/journal.pone.0261970","volume":"16","author":"M Amin","year":"2021","unstructured":"Amin M, Saha S, Islam M, Haider S, Hossain M, Chowdhury A, Rousham E, Islam M. High prevalence of plasmid-mediated quinolone resistance (PMQR) among E. coli from aquatic environments in Bangladesh. PLoS ONE. 2021;16(12):e0261970.","journal-title":"PLoS ONE"},{"issue":"4","key":"13953_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.21608\/ejmm.2022.265573","volume":"31","author":"G Mashaly","year":"2022","unstructured":"Mashaly G, Mohammed H, Nagib H. Plasmid Mediated Quinolone Resistance Genes (Qnr A and S) in Klebsiella pneumoniae Isolated from ICU Hospital Acquired Infection. Egypt J Med Microbiol. 2022;31(4):165\u201371.","journal-title":"Egypt J Med Microbiol"},{"key":"13953_CR48","doi-asserted-by":"crossref","unstructured":"Al-Agamy M, Aljallal A, Radwan H, Shibl A. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals. J Infect Public Health. 2018;11(1):64-8.","DOI":"10.1016\/j.jiph.2017.03.010"},{"issue":"5","key":"13953_CR49","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s11033-022-07215-5","volume":"49","author":"N Jomehzadeh","year":"2022","unstructured":"Jomehzadeh N, Saki M, Ahmadi K, Zandi G. The prevalence of plasmid-mediated quinolone resistance genes among Escherichia coli strains isolated from urinary tract infections in southwest Iran. Mol Biol Rep. 2022;49(5):3757\u201363.","journal-title":"Mol Biol Rep"},{"key":"13953_CR50","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/IDR.S203288","volume":"12","author":"M El-Badawy","year":"2019","unstructured":"El-Badawy M, Alrobaian M, Shohayeb M, Abdelwahab S. Investigation of six plasmid-mediated quinolone resistance genes among clinical isolates of Pseudomonas: a genotypic study in Saudi Arabia. Infect Drug Resist. 2019;12:915\u201323.","journal-title":"Infect Drug Resist"},{"key":"13953_CR51","doi-asserted-by":"publisher","first-page":"1719066","DOI":"10.3389\/fmicb.2025.1719066","volume":"16","author":"A Elbehiry","year":"2026","unstructured":"Elbehiry A, Marzouk E, Abalkhail A. Fluoroquinolone resistance in ESKAPE pathogens: evolutionary pathways, one health transmission, and clinical surveillance. Front Microbiol. 2026;16:1719066. https:\/\/doi.org\/10.3389\/fmicb.2025.1719066.","journal-title":"Front Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13953-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:20:39Z","timestamp":1785522039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13953"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13953-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The objectives and procedures of the study were approved by the Fayoum University Ethics Committee No: D249, Date 11-7-2021 Written informed consents were obtained from all participants after a clear clarification of the study\u2019s objectives. The study was conducted according to the principles of the Declaration of Helsinki. All methods were performed in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved the final version of the manuscript for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1413"}}